AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,845 | -$35,381 | -$26,665 | -$25,142 |
| Dep. & Amort. | $1,126 | $632 | $568 | $969 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13,496 | $8,384 | $6,998 | $6,331 |
| Change in WC | -$4,678 | -$6,574 | -$1,196 | -$1,728 |
| Other Non-Cash | $2,962 | -$5,072 | $1,205 | $1,533 |
| Operating Cash Flow | -$48,939 | -$38,011 | -$19,090 | -$18,037 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,171 | -$1,381 | -$452 | -$487 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$24,504 | -$78,757 | -$74,362 | $0 |
| Inv. Sales/Matur. | $71,200 | $81,811 | $55,555 | $0 |
| Other Inv. Act. | -$162 | -$66 | -$73 | -$49,721 |
| Investing Cash Flow | $37,363 | $1,607 | -$19,332 | -$50,208 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $38,762 | $0 | -$11 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,508 | $1,612 | $900 | $64,076 |
| Financing Cash Flow | $3,508 | $40,374 | $900 | $64,065 |
| Forex Effect | $0 | -$16 | -$26 | -$74 |
| Net Chg. in Cash | -$8,068 | $3,954 | -$37,548 | $37,107 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,118 | $18,164 | $55,712 | $73,840 |
| End Cash | $14,050 | $22,118 | $18,164 | $110,947 |
| Free Cash Flow | -$58,272 | -$39,458 | -$19,615 | -$18,524 |